Novo Nordisk vs Roche: Revenue Comparison
Novo Nordisk (NVO) and Roche (RHHBY) are peers in GLP-1. Novo Nordisk reported revenue of $96.8B as of Q1 2026, compared with $34.3B for Roche. Novo Nordisk leads on revenue.
Novo Nordisk's gross margin is 86.0% versus 71.7% for Roche. Novo Nordisk's net margin is 50.1% versus 17.9% for Roche.
Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q1 2026: Novo Nordisk 96.823, Roche 17.1305.
* Roche reports semi-annually. Values are evenly split across both quarters within each half.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Novo Nordisk, Roche.| Metric | Novo Nordisk | Roche |
|---|---|---|
| Market Cap | - | - |
| Revenue | $96.82B | $34.26B |
| Cost of Revenue | $13.60B | $9.68B |
| Gross Profit | $83.22B | $24.58B |
| Operating Income | $59.62B | $7.96B |
| Net Income | $48.56B | $6.13B |
| R&D Expense | $10.28B | $7.48B |
| Earnings Per Share | $10.91 | $0.95 |
| Gross Margin | 86.0% | 71.7% |
| Operating Margin | 61.6% | 23.2% |
| Net Profit Margin | 50.1% | 17.9% |
| Free Cash Flow | $12.04B | $10.67B |
| Cumulative Free Cash Flow | $654.97B | $299.34B |
| Operating Cash Flow | $24.08B | $13.12B |
| Cash & Equivalents | $21.13B | $6.32B |